Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (831-840 of 7,076) with videos related to

Pageof 708
Sort By:
Drugs|July 10, 1999
What is the place of fluoroquinolones in the treatment of community-acquired respiratory tract infections?H Momméja-Marin, C Carbon
Drugs|July 10, 1999
A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapyU Peitz, A Hackelsberger, P Malfertheiner
Drugs|January 1, 1975
Platelets, thrombosis and drugsJ F Mustard, M A Packham
Drugs|January 1, 1975
Diuretics: mechanism of action and clinical applicationD L Davies, G M Wilson
Drugs|August 10, 2000
Is there a growing role for endocrine therapy in the treatment of breast cancer?P E Lønning
Drugs|August 10, 2000
Current, new and future treatments in dyslipidaemia and atherosclerosisP H Chong, B S Bachenheimer
Drugs|January 1, 1985
The renin-angiotensin system in the control of systemic arterial pressureA B Ribeiro, O Kohlmann, M A Saragoça, et al.
Drugs|February 3, 2006
Perindopril: a review of its use in patients with or at risk of developing coronary artery diseaseMonique P Curran, Paul L McCormack, Dene Simpson
Drugs|December 18, 2007
Sevelamer hydrochloride: a review of its use for hyperphosphataemia in patients with end-stage renal disease on haemodialysisDavid R Goldsmith, Lesley J Scott, Risto S Cvetković, et al.
Drugs|December 18, 2007
RaltegravirJamie D Croxtall, Katherine A Lyseng-Williamson, Caroline M Perry
Pageof 708

Showing results (831-840 of 7,076) with videos related to

Sort By:
Pageof 708
Drugs|July 10, 1999
What is the place of fluoroquinolones in the treatment of community-acquired respiratory tract infections?H Momméja-Marin, C Carbon
Drugs|July 10, 1999
A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapyU Peitz, A Hackelsberger, P Malfertheiner
Drugs|January 1, 1975
Platelets, thrombosis and drugsJ F Mustard, M A Packham
Drugs|January 1, 1975
Diuretics: mechanism of action and clinical applicationD L Davies, G M Wilson
Drugs|August 10, 2000
Is there a growing role for endocrine therapy in the treatment of breast cancer?P E Lønning
Drugs|August 10, 2000
Current, new and future treatments in dyslipidaemia and atherosclerosisP H Chong, B S Bachenheimer
Drugs|January 1, 1985
The renin-angiotensin system in the control of systemic arterial pressureA B Ribeiro, O Kohlmann, M A Saragoça, et al.
Drugs|February 3, 2006
Perindopril: a review of its use in patients with or at risk of developing coronary artery diseaseMonique P Curran, Paul L McCormack, Dene Simpson
Drugs|December 18, 2007
Sevelamer hydrochloride: a review of its use for hyperphosphataemia in patients with end-stage renal disease on haemodialysisDavid R Goldsmith, Lesley J Scott, Risto S Cvetković, et al.
Drugs|December 18, 2007
RaltegravirJamie D Croxtall, Katherine A Lyseng-Williamson, Caroline M Perry
Pageof 708